-
Could Huntington Disease Gene Help Cure Mesothelioma?
There are many reasons that researchers consider malignant mesothelioma one of the most challenging cancers to treat. The reasons include: Mesothelioma has an extremely long latency period, sometimes taking as long as 50 years after the patient’s exposure to asbestos before its symptoms begin to appear. This means that patients’ disease is often more advanced,
-
Parasite Drug Tests Well on Mesothelioma Cells
In the quest for a medication that can stop malignant mesothelioma in its tracks, researchers are turning to both new technologies and innovative uses for old remedies, and this includes trying drugs that have proven successful against other illnesses on the rare and fatal form of cancer. Today, the Sbarro Health Research Organization announced that
-
Paper Mill Employee’s Mesothelioma Blamed on Asbestos in Dryer Felts
It’s been six years since Henry Barabin succumbed to malignant mesothelioma, but his widow Geraldine is still trying to get justice from those responsible for his illness. Barabin was a long-time employee of the Crown-Zellerback Pulp and Paper Mill located in Camas, Washington. He worked there between 1968 and 2001, holding a variety of jobs
-
What Mesothelioma Caregivers Need to Know About PTSD
As if a diagnosis of malignant mesothelioma isn’t challenging enough, researchers have found that mesothelioma patients and people diagnosed with other forms of cancer are particularly vulnerable to a diagnosis of post-traumatic stress disorder (PTSD). The condition is generally associated with military personnel and survivors of physically traumatic events such as shootings, terrorist attacks and
-
Proposed Indiana Law Would Directly Impact Mesothelioma Victims
The state of Indiana is poised to pass a law that would have a direct and extremely damaging impact on people diagnosed with malignant mesothelioma and other asbestos-related diseases. It would also position Indiana as the only state in the country not to carve out an exemption for the statute of repose for latent diseases
-
Family’s Mesothelioma Lawsuit Citing Scotts Turf Builder Will Have its Day in Court
Before Lorenz Brandecker died of malignant mesothelioma in October of 2012, he filed a lawsuit against the maker of Scotts Turf Builder, accusing the company of exposing him to the asbestos that caused his fatal illness. His claim was dismissed after Scotts successfully blocked testimony from his expert witnesses for not having based their opinions
-
UK Mesothelioma Research Program Announces Groundbreaking New Study
Mesothelioma patients in the U.S. tend to focus on treatment and research that is going on here within our own country. Malignant mesothelioma is a global problem, however. Developed nations around the world used asbestos in the same way that we did here. That means that their populations have been just as badly hurt, and
-
Memorial Sloan Kettering’s Mesothelioma Trial Combines Best of Two Treatments
Memorial Sloan Kettering Cancer Center is one of the world’s most highly respected cancer treatment and research facilities, so its recently-announced mesothelioma clinical trial is cause for hope and optimism. The new study, which will be open to mesothelioma patients diagnosed with either pleural mesothelioma or peritoneal mesothelioma, will combine the use of two of
-
Florida Courtroom Site of New Mesothelioma Trial Involving Exposure to Talc
A courtroom in Florida is the scene of the state’s first trial accusing a talc company of causing a man’s malignant mesothelioma. Lawsuits accusing asbestos companies of causing people’s mesothelioma have been with us for decades, and have resulted in billions of dollars in compensation being awarded to the victims of asbestos exposure. But a
-
Asbestos Found in Historic Texas Jail Spurs Mesothelioma Concerns
In addition to the devastation and displacement left behind by Hurricane Harvey, many Texas residents and employees are also facing new concerns about the risk of mesothelioma. As typically happens when structures are damaged by disaster, the storm damaged asbestos-contaminated building materials that have been in place for decades, exposing the public to the danger
-
Cancer Drug Developer Says Safety Must Be Prioritized In Drugs for Cancers, Including Mesothelioma
People who have been diagnosed with malignant mesothelioma have to pin their hopes for the future on advances in medicine, and that largely means on new cancer drugs. Despite the fact that the number of diagnosed cases of malignant mesothelioma are expected to rise in the next decades, there has been little real progress in
-
London Mesothelioma Patients Benefit From Dedicated Nurse Specialist
Mesothelioma patients being treated in the city of London will now have the benefit of having a second educated mesothelioma specialist nurse in place, thanks to a donation from the group Pat Stone Meso Support. The first such placement took place in late November of 2017, and the installation has been so immediately successful that
-
Fears of Mesothelioma Spark Legislative Action
In response to concerns about kids’ makeup raising the risk of malignant mesothelioma and other asbestos-related diseases, Michigan Congresswoman Debbie Dingell has introduced legislation requiring that all makeup products that are marketed to children be free of asbestos or carry a warning alerting parents of the presence of the carcinogenic material. Asbestos is a mineral
-
Why Mesothelioma Patients Should Have an Advanced Directive
Although mesothelioma is a lethal illness, medical innovations has provided some remarkable improvements in survival time, the prognosis for victims of this asbestos-related disease remains, on average, within two years of having been diagnosed. In the face of this reality, there are many steps you need to take to make sure that your affairs are
-
Mesothelioma Documentary to Premiere at International Film Festival
Most Americans’ only familiarity with malignant mesothelioma comes from television advertisements that urge victims to contact attorneys regarding filing lawsuits. The rare form of cancer affects fewer than 3,500 people in the United States each year, so raising awareness of the disease is a real challenge. That may change very soon, as word comes that
-
Vermont Mesothelioma Researchers Identify Essential Target for Stopping Disease
Finding a cure for malignant mesothelioma is the goal of researchers around the world, but it has proven to be extremely challenging. The highly aggressive condition attacks various parts of the body, and once the cancer’s tumors have begun to grow and spread, stopping it has been nearly impossible. In an effort to identify what
-
Michigan Research Reveals Potential Target for Drugs Treating Mesothelioma and Other Cancers
Malignant mesothelioma ranks among the most difficult forms of cancer to treat. The disease, which is caused by exposure to asbestos, is generally advanced at the time of its diagnosis, and has proven to be particularly resistant to chemotherapy and other traditional protocols. New research out of the University of Michigan may lead to an
-
Powerful New Pain Medication May Bring More Effective Relief for Mesothelioma Patients
When compared to other forms of cancer, malignant mesothelioma is unique in many ways. It’s generally only diagnosed when in an advanced stage; it is one of the only cancers that has a single and specifically known cause; and it is one of the only cancers for which no effective treatment has been found. Yet,
-
Noted Asbestos Expert Urging Novel Approach to Mesothelioma Screening
When it comes to expertise in asbestos exposure and its role in mesothelioma, few come close to Professor John Cherrie. In addition to his role as Professor of Human Health at Heriot Watt University in Edinburgh, Scotland, he is the Principal Scientist in the Research Division at IOM, one of the leading providers of workplace
-
Worldwide Mesothelioma Incidence Expected to Rise
A recent report tracking trends in medical research and drug development has forecast that the worldwide incidence of malignant mesothelioma is expected to rise in the next several years. It also details the continuing efforts into finding a cure for this rare and fatal form of cancer. Among the key takeaways for healthcare professionals, mesothelioma
